Mutation of the PDK1 PH Domain Inhibits Protein Kinase B/Akt, Leading to Small Size and Insulin Resistance

REFERENCES

• Alessi, D. R., M. Deak, A. Casamayor, F. B. Caudwell, N. Morrice, D. G. Norman, P. Gaffney, C. B. Reese, C. N. MacDougall, D. Harbison, A. Ashworth, and M. Bownes. 1997. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7:776–789.
   PubMed Web of Science ®Google Scholar
• Alessi, D. R., M. T. Kozlowski, Q. P. Weng, N. Morrice, and J. Avruch. 1998. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8:69–81.
   PubMed Web of Science ®Google Scholar
• Artunc, F., R. Rexhepaj, H. Volkl, F. Grahammer, C. Remy, D. Sandulache, O. Nasir, C. A. Wagner, D. R. Alessi, and F. Lang. 2006. Impaired intestinal and renal glucose transport in PDK-1 hypomorphic mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291:R1533–R1538.
   PubMedGoogle Scholar
• Balendran, A., A. Casamayor, M. Deak, A. Paterson, P. Gaffney, R. Currie, C. P. Downes, and D. R. Alessi. 1999. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol. 9:393–404.
   PubMed Web of Science ®Google Scholar
• Balendran, A., G. R. Hare, A. Kieloch, M. R. Williams, and D. R. Alessi. 2000. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett. 484:217–223.
   PubMed Web of Science ®Google Scholar
• Bayascas, J. R., N. R. Leslie, R. Parsons, S. Fleming, and D. R. Alessi. 2005. Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN(+/−) mice. Curr. Biol. 15:1839–1846.
   PubMed Web of Science ®Google Scholar
• Bhaskar, P. T., and N. Hay. 2007. The two TORCs and Akt. Dev. Cell 12:487–502.
   PubMed Web of Science ®Google Scholar
• Biondi, R. M. 2004. Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation. Trends Biochem. Sci. 29:136–142.
   PubMed Web of Science ®Google Scholar
• Biondi, R. M., P. C. Cheung, A. Casamayor, M. Deak, R. A. Currie, and D. R. Alessi. 2000. Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA. EMBO J. 19:979–988.
   PubMed Web of Science ®Google Scholar
• Calleja, V., D. Alcor, M. Laguerre, J. Park, B. Vojnovic, B. A. Hemmings, J. Downward, P. J. Parker, and B. Larijani. 2007. Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol. 5:e95.
   PubMedGoogle Scholar
• Chen, W. S., P. Z. Xu, K. Gottlob, M. L. Chen, K. Sokol, T. Shiyanova, I. Roninson, W. Weng, R. Suzuki, K. Tobe, T. Kadowaki, and N. Hay. 2001. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15:2203–2208.
   PubMed Web of Science ®Google Scholar
• Cho, H., J. Mu, J. K. Kim, J. L. Thorvaldsen, Q. Chu, E. B. Crenshaw III, K. H. Kaestner, M. S. Bartolomei, G. I. Shulman, and M. J. Birnbaum. 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728–1731.
   PubMed Web of Science ®Google Scholar
• Cho, H., J. L. Thorvaldsen, Q. Chu, F. Feng, and M. J. Birnbaum. 2001. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276:38349–38352.
   PubMed Web of Science ®Google Scholar
• Collins, B. J., M. Deak, J. S. Arthur, L. J. Armit, and D. R. Alessi. 2003. In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. EMBO J. 22:4202–4211.
   PubMed Web of Science ®Google Scholar
• Collins, B. J., M. Deak, V. Murray-Tait, K. G. Storey, and D. R. Alessi. 2005. In vivo role of the phosphate groove of PDK1 defined by knockin mutation. J. Cell Sci. 118:5023–5034.
   PubMedGoogle Scholar
• Currie, R. A., K. S. Walker, A. Gray, M. Deak, A. Casamayor, C. P. Downes, P. Cohen, D. R. Alessi, and J. Lucocq. 1999. Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem. J. 337:575–583.
   PubMedGoogle Scholar
• Dann, S. G., A. Selvaraj, and G. Thomas. 2007. mTOR complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 13:252–259.
   PubMed Web of Science ®Google Scholar
• Dummler, B., and B. A. Hemmings. 2007. Physiological roles of PKB/Akt isoforms in development and disease. Biochem. Soc. Trans. 35:231–235.
   PubMed Web of Science ®Google Scholar
• Dummler, B., O. Tschopp, D. Hynx, Z. Z. Yang, S. Dirnhofer, and B. A. Hemmings. 2006. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol. Cell. Biol. 26:8042–8051.
   PubMed Web of Science ®Google Scholar
• Easton, R. M., H. Cho, K. Roovers, D. W. Shineman, M. Mizrahi, M. S. Forman, V. M. Lee, M. Szabolcs, R. de Jong, T. Oltersdorf, T. Ludwig, A. Efstratiadis, and M. J. Birnbaum. 2005. Role for Akt3/protein kinase Bγ in attainment of normal brain size. Mol. Cell. Biol. 25:1869–1878.
   PubMed Web of Science ®Google Scholar
• Engelman, J. A., J. Luo, and L. C. Cantley. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7:606–619.
   PubMed Web of Science ®Google Scholar
• Fayard, E., J. Gill, M. Paolino, D. Hynx, G. A. Hollander, and B. A. Hemmings. 2007. Deletion of PKBα/Akt1 affects thymic development. PLoS ONE 2:e992.
   PubMedGoogle Scholar
• Fayard, E., L. A. Tintignac, A. Baudry, and B. A. Hemmings. 2005. Protein kinase B/Akt at a glance. J. Cell Sci. 118:5675–5678.
   PubMed Web of Science ®Google Scholar
• Garofalo, R. S., S. J. Orena, K. Rafidi, A. J. Torchia, J. L. Stock, A. L. Hildebrandt, T. Coskran, S. C. Black, D. J. Brees, J. R. Wicks, J. D. McNeish, and K. G. Coleman. 2003. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Investig. 112:197–208.
   PubMed Web of Science ®Google Scholar
• Gundersen, H. J., and E. B. Jensen. 1987. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147:229–263.
   PubMed Web of Science ®Google Scholar
• Hashimoto, N., Y. Kido, T. Uchida, S. Asahara, Y. Shigeyama, T. Matsuda, A. Takeda, D. Tsuchihashi, A. Nishizawa, W. Ogawa, Y. Fujimoto, H. Okamura, K. C. Arden, P. L. Herrera, T. Noda, and M. Kasuga. 2006. Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat. Genet. 38:589–593.
   PubMedGoogle Scholar
• Hauge, C., and M. Frodin. 2006. RSK and MSK in MAP kinase signalling. J. Cell Sci. 119:3021–3023.
   PubMed Web of Science ®Google Scholar
• Hinton, H. J., D. R. Alessi, and D. A. Cantrell. 2004. The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development. Nat. Immunol. 5:539–545.
   PubMed Web of Science ®Google Scholar
• King, C. C., and A. C. Newton. 2004. The adaptor protein Grb14 regulates the localization of 3-phosphoinositide-dependent kinase-1. J. Biol. Chem. 279:37518–37527.
   PubMedGoogle Scholar
• Kitamura, T., W. Ogawa, H. Sakaue, Y. Hino, S. Kuroda, M. Takata, M. Matsumoto, T. Maeda, H. Konishi, U. Kikkawa, and M. Kasuga. 1998. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell. Biol. 18:3708–3717.
   PubMed Web of Science ®Google Scholar
• Komander, D., A. Fairservice, M. Deak, G. S. Kular, A. R. Prescott, C. Peter Downes, S. T. Safrany, D. R. Alessi, and D. M. van Aalten. 2004. Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J. 23:3918–3928.
   PubMed Web of Science ®Google Scholar
• Lang, F., C. Bohmer, M. Palmada, G. Seebohm, N. Strutz-Seebohm, and V. Vallon. 2006. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol. Rev. 86:1151–1178.
   PubMed Web of Science ®Google Scholar
• Lawlor, M. A., A. Mora, P. R. Ashby, M. R. Williams, V. Murray-Tait, L. Malone, A. R. Prescott, J. M. Lucocq, and D. R. Alessi. 2002. Essential role of PDK1 in regulating cell size and development in mice. EMBO J. 21:3728–3738.
   PubMed Web of Science ®Google Scholar
• Li, X., B. Monks, Q. Ge, and M. J. Birnbaum. 2007. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator. Nature 447:1012–1016.
   PubMed Web of Science ®Google Scholar
• Lipina, C., X. Huang, D. Finlay, E. J. McManus, D. R. Alessi, and C. Sutherland. 2005. Analysis of hepatic gene transcription in mice expressing insulin-insensitive GSK3. Biochem. J. 392:633–639.
   PubMedGoogle Scholar
• Logie, L., A. J. Ruiz-Alcaraz, M. Keane, Y. L. Woods, J. Bain, R. Marquez, D. R. Alessi, and C. Sutherland. 2007. Characterisation of a protein kinase B inhibitor in vitro and in insulin treated liver cells. Diabetes 56:2218–2227.
   PubMed Web of Science ®Google Scholar
• Lucocq, J. M. 2007. Efficient quantitative morphological phenotyping of genetically altered organisms using stereology. Transgenic Res. 16:133–145.
   PubMedGoogle Scholar
• McManus, E. J., B. J. Collins, P. R. Ashby, A. R. Prescott, V. Murray-Tait, L. J. Armit, J. S. Arthur, and D. R. Alessi. 2004. The in vivo role of PtdIns(3,4,5)P(3) binding to PDK1 PH domain defined by knockin mutation. EMBO J. 23:2071–2082.
   PubMedGoogle Scholar
• Milburn, C. C., M. Deak, S. M. Kelly, N. C. Price, D. R. Alessi, and D. M. Van Aalten. 2003. Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. Biochem. J. 375:531–538.
   PubMed Web of Science ®Google Scholar
• Montagne, J., M. J. Stewart, H. Stocker, E. Hafen, S. C. Kozma, and G. Thomas. 1999. Drosophila S6 kinase: a regulator of cell size. Science 285:2126–2129.
   PubMed Web of Science ®Google Scholar
• Mora, A., A. M. Davies, L. Bertrand, I. Sharif, G. R. Budas, S. Jovanovic, V. Mouton, C. R. Kahn, J. M. Lucocq, G. A. Gray, A. Jovanovic, and D. R. Alessi. 2003. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J. 22:4666–4676.
   PubMed Web of Science ®Google Scholar
• Mora, A., D. Komander, D. M. Van Aalten, and D. R. Alessi. 2004. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15:161–170.
   PubMed Web of Science ®Google Scholar
• Mora, A., C. Lipina, F. Tronche, C. Sutherland, and D. R. Alessi. 2005. Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure. Biochem. J. 385:639–648.
   PubMedGoogle Scholar
• Murray, J. T., D. G. Campbell, N. Morrice, G. C. Auld, N. Shpiro, R. Marquez, M. Peggie, J. Bain, G. B. Bloomberg, F. Grahammer, F. Lang, P. Wulff, D. Kuhl, and P. Cohen. 2004. Exploitation of KESTREL to identify N-myc downstream-regulated gene family members as physiological substrates for SGK1 and GSK3. Biochem. J. 384:477–488.
   PubMed Web of Science ®Google Scholar
• Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281–296.
   PubMed Web of Science ®Google Scholar
• Nobukuni, T., S. C. Kozma, and G. Thomas. 2007. hvps34, an ancient player, enters a growing game: mTOR complex1/S6K1 signaling. Curr. Opin. Cell Biol. 19:135–141.
   PubMedGoogle Scholar
• Okamoto, Y., W. Ogawa, A. Nishizawa, H. Inoue, K. Teshigawara, S. Kinoshita, Y. Matsuki, E. Watanabe, R. Hiramatsu, H. Sakaue, T. Noda, and M. Kasuga. 2007. Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK1. Diabetes 56:1000–1009.
   PubMedGoogle Scholar
• Pende, M., S. H. Um, V. Mieulet, M. Sticker, V. L. Goss, J. Mestan, M. Mueller, S. Fumagalli, S. C. Kozma, and G. Thomas. 2004. S6K1−/−/S6K2−/− mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell Biol. 24:3112–3124.
   PubMed Web of Science ®Google Scholar
• Peng, X. D., P. Z. Xu, M. L. Chen, A. Hahn-Windgassen, J. Skeen, J. Jacobs, D. Sundararajan, W. S. Chen, S. E. Crawford, K. G. Coleman, and N. Hay. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17:1352–1365.
   PubMed Web of Science ®Google Scholar
• Rexhepaj, R., F. Grahammer, H. Volkl, C. Remy, C. A. Wagner, D. Sandulache, F. Artunc, G. Henke, S. Nammi, G. Capasso, D. R. Alessi, and F. Lang. 2006. Reduced intestinal and renal amino acid transport in PDK1 hypomorphic mice. FASEB J. 20:2214–2222.
   PubMedGoogle Scholar
• Rintelen, F., H. Stocker, G. Thomas, and E. Hafen. 2001. PDK1 regulates growth through Akt and S6K in Drosophila. Proc. Natl. Acad. Sci. USA 98:15020–15025.
   PubMedGoogle Scholar
• Sabatini, D. M. 2006. mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6:729–734.
   PubMed Web of Science ®Google Scholar
• Sancak, Y., C. C. Thoreen, T. R. Peterson, R. A. Lindquist, S. A. Kang, E. Spooner, S. A. Carr, and D. M. Sabatini. 2007. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25:903–915.
   PubMed Web of Science ®Google Scholar
• Stokoe, D., L. R. Stephens, T. Copeland, P. R. Gaffney, C. B. Reese, G. F. Painter, A. B. Holmes, F. McCormick, and P. T. Hawkins. 1997. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567–570.
   PubMed Web of Science ®Google Scholar
• Tschopp, O., Z. Z. Yang, D. Brodbeck, B. A. Dummler, M. Hemmings-Mieszczak, T. Watanabe, T. Michaelis, J. Frahm, and B. A. Hemmings. 2005. Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 132:2943–2954.
   PubMed Web of Science ®Google Scholar
• Verdu, J., M. A. Buratovich, E. L. Wilder, and M. J. Birnbaum. 1999. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat. Cell Biol. 1:500–506.
   PubMed Web of Science ®Google Scholar
• Voshol, P. J., G. Haemmerle, D. M. Ouwens, R. Zimmermann, R. Zechner, B. Teusink, J. A. Maassen, L. M. Havekes, and J. A. Romijn. 2003. Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology 144:3456–3462.
   PubMed Web of Science ®Google Scholar
• Whiteman, E. L., H. Cho, and M. J. Birnbaum. 2002. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13:444–451.
   PubMed Web of Science ®Google Scholar
• Williams, M. R., J. S. Arthur, A. Balendran, J. van der Kaay, V. Poli, P. Cohen, and D. R. Alessi. 2000. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10:439–448.
   PubMed Web of Science ®Google Scholar
• Wulff, P., V. Vallon, D. Y. Huang, H. Volkl, F. Yu, K. Richter, M. Jansen, M. Schlunz, K. Klingel, J. Loffing, G. Kauselmann, M. R. Bosl, F. Lang, and D. Kuhl. 2002. Impaired renal Na(+) retention in the sgk1-knockout mouse. J. Clin. Investig. 110:1263–1268.
   PubMed Web of Science ®Google Scholar
• Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124:471–484.
   PubMed Web of Science ®Google Scholar
• Yang, Z. Z., O. Tschopp, N. Di-Poi, E. Bruder, A. Baudry, B. Dummler, W. Wahli, and B. A. Hemmings. 2005. Dosage-dependent effects of Akt1/protein kinase Bα (PKBα) and Akt3/PKBγ on thymus, skin, and cardiovascular and nervous system development in mice. Mol. Cell. Biol. 25:10407–10418.
   PubMed Web of Science ®Google Scholar
• Yang, Z. Z., O. Tschopp, M. Hemmings-Mieszczak, J. Feng, D. Brodbeck, E. Perentes, and B. A. Hemmings. 2003. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J. Biol. Chem. 278:32124–32131.
   PubMed Web of Science ®Google Scholar
• Zaru, R., N. Ronkina, M. Gaestel, J. S. Arthur, and C. Watts. 2007. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat. Immunol. 8:1227–1235.
   PubMed Web of Science ®Google Scholar